Literature DB >> 16800740

Expression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissues.

Chris Planque1, Mireille Aïnciburu, Nathalie Heuzé-Vourc'h, Sandra Régina, Michèle de Monte, Yves Courty.   

Abstract

Only one transcript for KLK10 was identified by RT-PCR in lung tissue, whereas KLK11 expressed at least four alternative transcripts. Quantitative analysis of KLK10 and KLK11 expression levels was assessed by real-time PCR, in a cohort of 47 patients with non-small-cell lung cancer (NSCLC). Expression levels of these genes were widely distributed in the population studied. Multivariate analysis revealed a correlation between KLK10 over-expression and the squamous cell carcinoma histotype (p=0.034). There was no correlation between gene expression and patient survival. Overall, both genes behaved similarly (p<0.001). These results suggest a co-regulation of KLK10 and KLK11 expression in lung and a lack of KLK10 suppressor role in NSCLC. Finally, our findings indicate that these genes are likely involved in normal physiology processes in bronchus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16800740     DOI: 10.1515/BC.2006.098

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  5 in total

1.  Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer.

Authors:  Imran Nawaz; Xiaoming Qiu; Heng Wu; Yang Li; Yaguang Fan; Li-Fu Hu; Qinghua Zhou; Ingemar Ernberg
Journal:  Epigenetics       Date:  2014-06-17       Impact factor: 4.528

2.  Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients.

Authors:  Xiaocong Geng; Yueyang Liu; Tobias Dreyer; Holger Bronger; Enken Drecoll; Viktor Magdolen; Julia Dorn
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

3.  High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis.

Authors:  Heuzé-Vourc'h Nathalie; Planque Chris; Guyetant Serge; Coco Catherine; Brillet Benjamin; Blechet Claire; Parent Christelle; Laurent Briollais; Reverdiau Pascale; Jourdan Marie-Lise; Courty Yves
Journal:  J Cell Mol Med       Date:  2009-05-01       Impact factor: 5.310

4.  Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer.

Authors:  Xiaocong Geng; Yueyang Liu; Sandra Diersch; Matthias Kotzsch; Sabine Grill; Wilko Weichert; Marion Kiechle; Viktor Magdolen; Julia Dorn
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

5.  Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.

Authors:  Prashant D Tailor; Sai Karthik Kodeboyina; Shan Bai; Nikhil Patel; Shruti Sharma; Akshay Ratnani; John A Copland; Jin-Xiong She; Ashok Sharma
Journal:  Oncotarget       Date:  2018-04-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.